Vanguard reports 4.88% stake in Hyster-Yale
The Vanguard Group reported beneficial ownership of 698,331 shares of Hyster-Yale Inc common stock, representing 4.88% of the class as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group reported beneficial ownership of 698,331 shares of Hyster-Yale Inc common stock, representing 4.88% of the class as of 12/31/2025.
Vanguard reports no sole voting or dispositive power, with shared voting power over 94,909 shares and shared dispositive power over all 698,331 shares. The shares are held on behalf of Vanguard’s clients, who are entitled to dividends and sale proceeds, and no single client holds more than 5% of the class. Vanguard also notes an internal realignment effective January 12, 2026, after which certain subsidiaries are expected to report beneficial ownership separately while pursuing the same investment strategies.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake does The Vanguard Group report in Hyster-Yale (HY)?
Why does Vanguard say it owns 5 percent or less of Hyster-Yale (HY)?
Who ultimately benefits from Vanguard’s Hyster-Yale (HY) holdings?
What internal realignment at Vanguard is mentioned in the Hyster-Yale (HY) filing?
Does Vanguard seek to influence control of Hyster-Yale (HY) with this stake?
AI-generated analysis. How Rhea-AI works. Not financial advice.